Delic Holdings Corp (“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced that George Goldsmith and Ekaterina Malievskaia, M.D., will serve as headline speakers at Meet Delic on November 6. Goldsmith is the CEO and founder of COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Dr. Malievskaia is the Chief Innovation Officer and co-founder of COMPASS and received her medical degree from St. Petersburg Medical Academy in St. Petersburg, Russia, before moving to the U.S. where she completed her Internal Medicine residency training. COMPASS is a public company based out of the U.K. whose first major initiative is developing psilocybin therapy through late-stage clinical trials in Europe and North America for people with treatment-resistant depression.
Meet Delic is the largest and most comprehensive event to learn about the intersection of psychedelics, wellness, and business with like-minded visionaries. Goldsmith and Dr. Malievskaia’s keynote interview, ‘A Discussion with George Goldsmith & Ekaterina Malievskaia featuring Clara Burtenshaw‘, will explore what COMPASS’s vision of “a world of mental wellbeing” means, including how COMPASS is building a pipeline of psychedelic therapies for mental health illnesses, supported by rigorous science, extensive therapist training, and digital technology.
“There are far too many people suffering with mental health challenges, who aren’t helped by existing therapies,” said Goldsmith. “We are working hard to change that – and to develop the evidence that health systems require to ensure innovation is accessible to the patients who need it.”
Dr. Malievskaia said, “I am excited to share our vision with the Delic community and to dive into a meaningful dialogue on the future of psychedelics and mental health.”
Meet Delic is committed to bringing awareness of the science-backed benefits of psychedelics and business opportunities to the mainstream and larger global community by reframing the psychedelic conversation. The experiential event will feature dancers, music, 3D-mapping, visual artists, new technologies and research, thought-provoking presentations and one of the world’s largest psychedelic business expo.
“We are thrilled to have George and Ekaterina speak at our conference and share their passion for finding a new approach to mental health care,” said Delic co-founder, Jackee Stang. “They are on the cutting edge of innovative therapies, including research into the use of psilocybin for treatment-resistant depression, and their experience will be invaluable to the discussion.”
The twenty hours of panels and keynotes will include an array of topics such as Accelerating Adaptation: What Psychedelic States can teach us about Healing, Aphrodisiacs and Psychedelics: A History of Medicine for Love, Fentanyl in our Drugs, Ketamine: An Intimate Discussion on the New Wonder Drug for PTSD, Deciphering the Medical Potential of Psychedelics, A Discussion with George Goldsmith & Ekaterina Malievskaia featuring Clara Burtenshaw, Psychedelics and Futurism. Musical and entertainment acts are scheduled both evenings following the panels and expo.
Meet Delic is a subsidiary of Delic, which is focused on bringing psychedelic wellness to the mainstream. The company does this through an umbrella of related owned and operated businesses to support scaling the impact and reach of treatment, including 1) trusted media and e-commerce platforms and in-person events like Meet Delic to market the services directly to patients and consumers and gain data, 2) a licensed lab to develop IP, R&D and innovative high quality and safe product lines and 3) the largest and most accessible network of physical clinics to administer effective treatments.